During the process of melanogenesis, hydroxylation of L-tyrosine to form L-3,4-dihydroxyphenylalanine (L-DOPA) is the rate-limiting step of the whole process, which is catalyzed by TYR
Hetero launches its generic semaglutide portfolio in international markets, enhancing access to advanced diabetes and obesity therapies
Meeting the Growing Demand for Compounded Tirzepatide With the increasing need for effective weight management treatments, ensuring a reliable medication supply is more important than ever
Ipamorelin is a pentapeptide (a chain of five amino acids) that was developed by Novo Nordisk, a Danish pharmaceutical company
From Nafld to Mafld: when pathophysiology succeeds
The SELECT trial showed a 20% drop in major heart events (heart attack, stroke, cardiovascular death) in people with obesity and existing heart disease